Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Basile Chretien

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
The Breast Journal|October 24, 2020
Abemaciclib-induced reversible grade 4 nephrotoxicityAngélique Da Silva, Basile Chretien, Joachim Alexandre, et al.
Cancer Science|January 31, 2025
Genomic profiles of patients with skin melanoma in the era of immune checkpoint inhibitorsYao Liang, Osamu Maeda, Kazuki Nishida, et al.
Journal of Gastroenterology|June 26, 2026
Vonoprazan is associated with a phenotype-specific increase in cholangitis reporting in immune checkpoint inhibitor-treated patients: a VigiBase pharmacovigilance studyKazuyuki Mizuno, Basile Chretien, Kazuki Nishida, et al.
Scientific Reports|December 16, 2025
Analysis of anticancer drug associated adverse reactions in depressive patients from vigibaseBasile Chretien, Charles Dolladille, Kazuki Nishida, et al.
BMJ Open|November 27, 2025
Association between exposure to proton pump inhibitors and hypertension: a descriptive and disproportionality analysis of VigiBaseBasile Chretien, Matthieu Cacquevel, Nishida Kazuki, et al.
Journal of Neurology|December 16, 2025
Guillain-Barré syndrome associated with immune checkpoint inhibitors exposure: a pharmacovigilance studyJean Cabon, Mathilde Ducloie, Basile Chretien, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 24, 2021
A Worldwide Pharmacoepidemiologic Update on Drug-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the Era of Targeted TherapiesSamuel Deshayes, Charles Dolladille, Anaël Dumont, et al.
Frontiers in Pharmacology|November 6, 2023
Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization's databaseRachel Prevost, Basile Chretien, Elise-Marie Minoc, et al.
Journal of Bronchology & Interventional Pulmonology|September 4, 2025
How Does the Diagnostic Effectiveness of Transbronchial Needle Aspiration/Transbronchial Biopsy With Radial Endobronchial Ultrasound for the Diagnosis of Peripheral Pulmonary Lesions Differ With and Without a Guide Sheath?Takayasu Ito, Basile Chretien, Kazuki Nishida, et al.
Fundamental & Clinical Pharmacology|February 24, 2026
Medical Cannabis Use in France: An Observational Safety Study Based on the RECANN Registry and the Pharmacovigilance/Addictovigilance System From 2021 to 2024Cécile Chevallier, Anne Batisse, Emilie Monzon, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The Breast Journal|October 24, 2020
Abemaciclib-induced reversible grade 4 nephrotoxicityAngélique Da Silva, Basile Chretien, Joachim Alexandre, et al.
Cancer Science|January 31, 2025
Genomic profiles of patients with skin melanoma in the era of immune checkpoint inhibitorsYao Liang, Osamu Maeda, Kazuki Nishida, et al.
Journal of Gastroenterology|June 26, 2026
Vonoprazan is associated with a phenotype-specific increase in cholangitis reporting in immune checkpoint inhibitor-treated patients: a VigiBase pharmacovigilance studyKazuyuki Mizuno, Basile Chretien, Kazuki Nishida, et al.
Scientific Reports|December 16, 2025
Analysis of anticancer drug associated adverse reactions in depressive patients from vigibaseBasile Chretien, Charles Dolladille, Kazuki Nishida, et al.
BMJ Open|November 27, 2025
Association between exposure to proton pump inhibitors and hypertension: a descriptive and disproportionality analysis of VigiBaseBasile Chretien, Matthieu Cacquevel, Nishida Kazuki, et al.
Journal of Neurology|December 16, 2025
Guillain-Barré syndrome associated with immune checkpoint inhibitors exposure: a pharmacovigilance studyJean Cabon, Mathilde Ducloie, Basile Chretien, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 24, 2021
A Worldwide Pharmacoepidemiologic Update on Drug-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the Era of Targeted TherapiesSamuel Deshayes, Charles Dolladille, Anaël Dumont, et al.
Frontiers in Pharmacology|November 6, 2023
Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization's databaseRachel Prevost, Basile Chretien, Elise-Marie Minoc, et al.
Journal of Bronchology & Interventional Pulmonology|September 4, 2025
How Does the Diagnostic Effectiveness of Transbronchial Needle Aspiration/Transbronchial Biopsy With Radial Endobronchial Ultrasound for the Diagnosis of Peripheral Pulmonary Lesions Differ With and Without a Guide Sheath?Takayasu Ito, Basile Chretien, Kazuki Nishida, et al.
Fundamental & Clinical Pharmacology|February 24, 2026
Medical Cannabis Use in France: An Observational Safety Study Based on the RECANN Registry and the Pharmacovigilance/Addictovigilance System From 2021 to 2024Cécile Chevallier, Anne Batisse, Emilie Monzon, et al.
Pageof 3